Published in Clinical Cancer Research, results of a VHIO-led study underscore the potential of the RAD51 biomarker in ...

The following is a summary of “Evaluating Digital Rehabilitation Outcomes in Chronic Musculoskeletal Conditions Across Non-Obesity, Obesity, and Severe Obesity,” published in the January 2025 issue of ...

Serum level of inflammatory marker C-reactive protein (CRP) predicted response to adalimumab (Humira) treatment for patients ...

“The GeparOla trial included patients with early HER2-negative breast cancer who had homologous recombination deficiency, HRD ...

One year after the second vaccine dose, the anti-gE antibody immune response to amezosvatein continues to be non-inferior to ShingrixSEATTLE, ...

NeurIPS, the biggest AI research conference, turned Vancouver’s convention center into a battleground for wooing AI talent.

Ahead of his second term, an emboldened Trump has articulated a vision of hemispheric expansionism. What’s he playing at?

A recent analysis of the PEXIVAS trial showed that plasma exchange can significantly improve kidney function in patients with AAV and kidney involvement.

Proenkephalin A 119-159 (penKid) demonstrates potential as a predictor for successful discontinuation of continuous renal replacement therapy (CRRT) in cardiac surgery patients. Study reveals ...

DBV Technologies (DBVT) announced twenty-four month results from its Open-Label Extension Study of EPITOPE. The data provide support that ...

With high biologic treatment failure rates common among patients who have hidradenitis suppurativa (HS), investigators set ...

Tyr Pharma's stock surged on positive data for pulmonary sarcoidosis treatment, but cash balance risk keeps investors ...